Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

Emerging drugs for non-alcoholic fatty liver disease

“……”

Emerging drugs for non-alcoholic fatty liver disease

“……”

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

“…112,113 A search for ongoing trials or reviews was carried out. An out-of-date Cochrane review on insulin sensitisers by Angelico et al, 114 in Rome, was found. It excluded people with T2DM, and included only three trials: two of metformin and one of pioglitazone.…”

Histological study on the effect of metformin on high-fat-diet-induced liver injury in adult male albino rats

“…Pharmacological treatment of patients with NAFLD is still developing, and, as IR plays a key role in the pathogenesis of NAFLD, insulin-sensitizing drugs such as metformin are suggested to provide promising treatment for NAFLD [12,13].…”

Emerging drugs for non-alcoholic fatty liver disease

“……”

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

“…112,113 A search for ongoing trials or reviews was carried out. An out-of-date Cochrane review on insulin sensitisers by Angelico et al, 114 in Rome, was found. It excluded people with T2DM, and included only three trials: two of metformin and one of pioglitazone.…”

Histological study on the effect of metformin on high-fat-diet-induced liver injury in adult male albino rats

“…Pharmacological treatment of patients with NAFLD is still developing, and, as IR plays a key role in the pathogenesis of NAFLD, insulin-sensitizing drugs such as metformin are suggested to provide promising treatment for NAFLD [12,13].…”

Emerging drugs for non-alcoholic fatty liver disease

“……”

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

“…112,113 A search for ongoing trials or reviews was carried out. An out-of-date Cochrane review on insulin sensitisers by Angelico et al, 114 in Rome, was found. It excluded people with T2DM, and included only three trials: two of metformin and one of pioglitazone.…”

Histological study on the effect of metformin on high-fat-diet-induced liver injury in adult male albino rats

“…Pharmacological treatment of patients with NAFLD is still developing, and, as IR plays a key role in the pathogenesis of NAFLD, insulin-sensitizing drugs such as metformin are suggested to provide promising treatment for NAFLD [12,13].…”